H Lundbeck A/S
CSE:HLUN A
H Lundbeck A/S
CSE:HLUN A
Price:
34.65
DKK
-0.72%
Market Cap:
kr34.5B
Relative Value
The Relative Value of one
HLUN A
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 34.65 DKK,
H Lundbeck A/S
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HLUN A Relative Value
HIDDEN
Multiples Across Competitors
HLUN A Competitors Multiples
H Lundbeck A/S Competitors
H Lundbeck A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
H Lundbeck A/S
CSE:HLUN A
|
34.4B DKK | 1.4 | 10.8 | 5.3 | 6.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD | 14.8 | 46.9 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD | 6.3 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
295B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.3B CHF | 5.7 | 22.8 | 14.1 | 18.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.5B GBP | 5.4 | 30.8 | 17.1 | 24 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD | 4.6 | 16.6 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
